Showing results (1761-1770 of 1,902) with videos related to
Sort By:
Pageof 191
International Journal of Particle Therapy|July 21, 2021
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal CancerGrace L Smith, Shuangshuang Fu, Matthew S Ning, et al.Brachytherapy|July 3, 2025
Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physiciansMira Keyes, Alina Emiliana Sturdza, Juanita Crook, et al.Head & Neck|May 3, 2017
Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynxJay C Shiao, Abdallah S R Mohamed, Jay A Messer, et al.ESMO Open|February 13, 2024
Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trialS Michels, B Massutí, I Vasyliv, et al.Journal for Immunotherapy of Cancer|July 2, 2024
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphomaSushma Bharadwaj, Eric Lau, Mark P Hamilton, et al.The Journal of Experimental Medicine|June 20, 2020
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialMatthew J Frank, Michael S Khodadoust, Debra K Czerwinski, et al.Clinical and Translational Radiation Oncology|August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer centerAlan J Sosa, Michael K Rooney, Howard D Thames, et al.Blood Advances|July 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysisNausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, et al.Oral Oncology|March 31, 2018
Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancerMona Kamal, Sweet Ping Ng, Salman A Eraj, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T ConsortiumYucai Wang, Preetesh Jain, Frederick L Locke, et al.Pageof 191